StockWatch
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionJun 22, 2026, 04:22 PM

PRF Technologies Enters $15M Equity Purchase Agreement with YA

AI Summary

PRF Technologies Ltd. entered into a Standby Equity Purchase Agreement (SEPA) with YA, enabling the company to sell up to $15.0 million in ordinary shares to YA over a 36-month period. This agreement aims to raise capital for research and development, working capital, and general corporate purposes. However, the potential issuance of up to 7,500,000 shares, representing approximately 247% of current outstanding shares, carries a significant risk of substantial dilution and share price decline for existing shareholders. The company had previously terminated a $10.0 million SEPA with YA in May 2026.

Key Highlights

  • Entered Standby Equity Purchase Agreement (SEPA) with YA for up to $15.0M.
  • Company can sell up to $15.0M in ordinary shares to YA over 36 months.
  • 7,500,000 ordinary shares registered for resale by YA, including 20,276 Commitment Shares.
  • YA to purchase shares at 97% of lowest three daily volume weighted average prices (VWAPs).
  • Potential for substantial dilution to existing shareholders, approximately 247% of current shares.
  • Proceeds to fund research and development, working capital, and general corporate purposes.
  • Previous $10.0M SEPA with YA terminated on May 29, 2026.
  • Company changed name to PRF Technologies Ltd. on January 15, 2026.